All sponsors

CStone Pharmaceuticals

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-19
ACTIVE TRIALS5
PHASE 3 / 2-32
RECRUITING1
READOUTS ≤12 MONTHS1
Open CStone Pharmaceuticals on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
Lorlatinib
NCT05297890
P2Active, not recruitingAdvanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer702023-12-26
Nofazinlimab (CS1003)+Lenvatinib
NCT04194775
P3Active, not recruitingHepatocellular Carcinoma5342025-06-18 (+24 mo)
CS2009
NCT06741644
P1/2RecruitingAdvanced Solid Tumors8002027-01
CS5006
NCT07938814
P1/2Not yet recruitingAdvanced Solid Tumors3102029-07
Sugemalimab
NCT05700448
P3Not yet recruitingExtranodal NK/T-cell Lymphoma1502029-12 (+38 mo)